Impact of diagnostics on antimicrobial prescribing


Accueil Synopsis programme Test CME
Impact of diagnostics on antimicrobial prescribing 12 July 2021 5. New antibacterial agents, PK/PD & Stewardship, 1-hour Oral Session • S16 • 10:45 > 11:45 • Impact of diagnostics on antimicrobial prescribing • 5. Antimicrobials & stewardship 10:45 • 14 • Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of <em>Pseudomonas aeruginosa</em> infections: an observational study in a university hospital > A. Aline MUNTING (Lausanne) 10:55 • 294 • Transition to molecular-based diagnosis of stool pathogens: diagnostic stewardship and antibiotic consumption > D. David SHASHA (Ramat Gan) 11:05 • 1736 • A diagnostic randomised controlled trial to study the impact of rapid diagnostic tests in patients with acute febrile illness when compared to conventional diagnostics (DRACO study) > N. Nitin GUPTA (Udupi) 11:15 • 4133 • Colonisation-guided approach to empirical therapy and antimicrobial stewardship in allogeneic haematopoietic stem cell transplantation (allo HSCT) > M. Marina POPOVA (Saint Petersburg) 11:25 • 178 • Understanding prescribers' beliefs about molecular diagnostic tests as barriers and facilitators to test uptake in intensive care units (ICUs): a qualitative study > A. Alyssa Megan PANDOLFO (London) 11:35 • INT81 • Q&A/Discussion